EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Folic Acid Supplementation in Spina Bifida Prophylaxis: Results from the Zurich Fetal Surgery Cohort

Martina Hofmann, Julia Wawrla-Zepf, Ladina Rüegg, Nele Strübing, Martin Meuli, Ueli Moehrlen, Nicole Ochsenbein-Kölble, Ladina Vonzun

Fetal Diagnosis and Therapy · 2025

DOI: 10.1159/000547609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, 2025. Verfasst von Martina Hofmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Folic Acid, Spinal Dysraphism, Dietary Supplements. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Since preconceptional folic acid (FA) supplementation is known to reduce the risk of fetal spina bifida (fSB), the aim of this study was to systematically analyze the FA supplementation in a cohort of women with fSB repair in affected and subsequent pregnancies.

Methods

A total of 198 women, that underwent open fSB repair between 2010 and 2023, were compared in two groups (group 1 = correct FA and group 2 = incorrect FA preconceptionally) regarding maternal and fetal characteristics. Additionally, compliance to high dose FA supplementation in subsequent pregnancies was analyzed.

Results

Sixty-five women (32.8%) had correct preconceptional FA supplementation (group 1), and 63 women (31.8%) had incorrect FA supplementation (group 2). The two groups did not significantly differ regarding maternal and fetal characteristics. Thirty-nine women had 48 subsequent pregnancies. FA was initiated prior to conception in 35 (72.9%) of these pregnancies, in 9 (18.7%) cases, FA supplementation was incorrect.

Conclusion

This study focuses on better awareness of FA supplementation as correct FA supplementation was low in women with fSB and suboptimal in high-risk situations after fSB pregnancies. However, these results also show that 1/2 of fSB occurs despite correct FA intake; thus, further research is needed to better understand the complex, multifactorial causes of this debilitating condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Folic AcidSpinal DysraphismDietary SupplementsHumansFemalePregnancyAdultCohort StudiesPreconception CareRetrospective Studies

Stichwörter der Autor:innen

FolateFolic acid supplementationSpina bifidaSubsequent pregnancy

Substanzen

Folic Acid

Autor:innen und Institutionen

  • Department of Obstetrics, University Hospital Zurich, Zurich, Switzerland.
  • Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • The Zurich Center for Fetal Diagnosis and Therapy, University of Zurich, Zurich, Switzerland.
  • SPINA BIFIDA STUDY GROUP ZURICH, Zurich, Switzerland.
  • Department of Pediatric Surgery, University Children 's Hospital Zurich, Zurich, Switzerland.
  • Department of Obstetrics, University Hospital Zurich, Zurich, Switzerland, ladina.vonzun@usz.ch.

Zitieren

APA

Hofmann, M., Wawrla-Zepf, J., Rüegg, L., Strübing, N., Meuli, M., Moehrlen, U., Ochsenbein-Kölble, N., & Vonzun, L. (2025). Folic Acid Supplementation in Spina Bifida Prophylaxis: Results from the Zurich Fetal Surgery Cohort. Fetal Diagnosis and Therapy. https://doi.org/10.1159/000547609

Vancouver

Hofmann M, Wawrla-Zepf J, Rüegg L, Strübing N, Meuli M, Moehrlen U, et al. Folic Acid Supplementation in Spina Bifida Prophylaxis: Results from the Zurich Fetal Surgery Cohort. Fetal Diagnosis and Therapy. 2025. doi:10.1159/000547609

BibTeX
@article{Hofmann2025,
  author = {Hofmann, Martina and Wawrla-Zepf, Julia and Rüegg, Ladina and Strübing, Nele and Meuli, Martin and Moehrlen, Ueli and Ochsenbein-Kölble, Nicole and Vonzun, Ladina},
  title = {Folic Acid Supplementation in Spina Bifida Prophylaxis: Results from the Zurich Fetal Surgery Cohort},
  journal = {Fetal Diagnosis and Therapy},
  year = {2025},
  doi = {10.1159/000547609}
}
Kostenlos starten →